Luke F. Poloniecki

Mr. Luke F.
Poloniecki is an Analyst at Edison Investment Research Ltd.
He joined Edison’s healthcare team in November 2012 from ING, where he was a vice president in its equity research team, covering Benelux Biotech and Emerging Market pharmaceutical names.
He has seven years’ experience as a pharma and biotech analyst, working in London and Paris at Société Générale and Bryan Garnier on sell-side coverage and ECM deals.
Prior to investment banking, he acquired two years’ experience in the pharmaceutical industry working for Schering-Plough on its cardiovascular, respiratory and allergy franchises.
Mr. Poloniecki holds a BSc (Hons) in human physiology from Newcastle University and the University of Rennes.
He is a holder of the Association of the British Pharmaceutical Industry (ABPI) sales qualification.